Evolution of drug resistance in experimental populations of Candida albicans - PubMed (original) (raw)
Evolution of drug resistance in experimental populations of Candida albicans
L E Cowen et al. J Bacteriol. 2000 Mar.
Abstract
Adaptation to inhibitory concentrations of the antifungal agent fluconazole was monitored in replicated experimental populations founded from a single, drug-sensitive cell of the yeast Candida albicans and reared over 330 generations. The concentration of fluconazole was maintained at twice the MIC in six populations; no fluconazole was added to another six populations. All six replicate populations grown with fluconazole adapted to the presence of drug as indicated by an increase in MIC; none of the six populations grown without fluconazole showed any change in MIC. In all populations evolved with drug, increased fluconazole resistance was accompanied by increased resistance to ketoconazole and itraconazole; these populations contained ergosterol in their cell membranes and were amphotericin sensitive. The increase in fluconazole MIC in the six populations evolved with drug followed different trajectories, and these populations achieved different levels of resistance, with distinct overexpression patterns of four genes involved in azole resistance: the ATP-binding cassette transporter genes, CDR1 and CDR2; the gene encoding the target enzyme of the azoles in the ergosterol biosynthetic pathway, ERG11; and the major facilitator gene, MDR1. Selective sweeps in these populations were accompanied by additional genomic changes with no known relationship to drug resistance: loss of heterozygosity in two of the five marker genes assayed and alterations in DNA fingerprints and electrophoretic karyotypes. These results show that chance, in the form of mutations that confer an adaptive advantage, is a determinant in the evolution of azole drug resistance in experimental populations of C. albicans.
Figures
FIG. 1
Adaptation to fluconazole in experimental populations. Twelve populations were established from a single cell of an azole-susceptible strain of C. albicans. The populations were propagated in RPMI 1640 medium for 330 generations. Six populations (D7 to D12) were grown in twice their most recently measured MIC of fluconazole, and six (N1 to N6) were grown without drug.
FIG. 2
The stability of acquired resistance in 50 generations (∼15 days) in RPMI 1640 medium without fluconazole. Susceptibility to fluconazole was determined at generations 0 (solid), 25 (hatched), and 50 (unfilled). M refers to mass cultures; S refers to a single-colony isolate.
FIG. 3
Relative mRNA levels of four C. albicans genes involved in azole resistance. Bars represent standard deviations for each sample (n = 6 replicate measurements). Variation among the population samples was highly significant (Kruskal-Wallis test, P < 0.001).
FIG. 4
Electrophoretic karyotypes. (Top panels) Ethidium-stained gels. The arrow indicates chromosome R in isolate T118-0; the bracket indicates range of chromosome R sizes in other isolates. (Middle panels) Southern hybridization with INO1 (GenBank accession no. L22737), a probe specific for chromosome R. The asterisk indicates the strongly hybridizing band in T118-0; the open arrow indicates the weakly hybridizing band of unknown origin in T118-0. (Bottom panels) rDNA as visualized by Southern hybridization of _Hin_dIII digests with the intergenic spacer region of the rDNA.
FIG. 5
Doubling times of populations during the exponential growth phase. (A) Doubling times in RPMI 1640 medium. (B) Doubling times in yeast-peptone-glucose medium. Bars represent standard deviation for each sample (n = 2 replicate measurements). Variation among the population samples was highly significant (Kruskal-Wallis test, P < 0.001).
Similar articles
- Mechanisms of resistance to azole antifungal agents in Candida albicans isolates from AIDS patients involve specific multidrug transporters.
Sanglard D, Kuchler K, Ischer F, Pagani JL, Monod M, Bille J. Sanglard D, et al. Antimicrob Agents Chemother. 1995 Nov;39(11):2378-86. doi: 10.1128/AAC.39.11.2378. Antimicrob Agents Chemother. 1995. PMID: 8585712 Free PMC article. - Mechanisms of resistance to fluconazole in Candida albicans clinical isolates from Iranian HIV-infected patients with oropharyngeal candidiasis.
Salari S, Khosravi AR, Mousavi SA, Nikbakht-Brojeni GH. Salari S, et al. J Mycol Med. 2016 Mar;26(1):35-41. doi: 10.1016/j.mycmed.2015.10.007. Epub 2015 Nov 25. J Mycol Med. 2016. PMID: 26627124 - Activity of Isavuconazole and Other Azoles against Candida Clinical Isolates and Yeast Model Systems with Known Azole Resistance Mechanisms.
Sanglard D, Coste AT. Sanglard D, et al. Antimicrob Agents Chemother. 2015 Oct 19;60(1):229-38. doi: 10.1128/AAC.02157-15. Print 2016 Jan. Antimicrob Agents Chemother. 2015. PMID: 26482310 Free PMC article. - The genetic basis of fluconazole resistance development in Candida albicans.
Morschhäuser J. Morschhäuser J. Biochim Biophys Acta. 2002 Jul 18;1587(2-3):240-8. doi: 10.1016/s0925-4439(02)00087-x. Biochim Biophys Acta. 2002. PMID: 12084466 Review. - Antifungal drug resistance in pathogenic fungi.
Vanden Bossche H, Dromer F, Improvisi I, Lozano-Chiu M, Rex JH, Sanglard D. Vanden Bossche H, et al. Med Mycol. 1998;36 Suppl 1:119-28. Med Mycol. 1998. PMID: 9988500 Review.
Cited by
- Single-cell detection of copy number changes reveals dynamic mechanisms of adaptation to antifungals in Candida albicans.
Zhou X, Hilk A, Solis NV, Scott N, Beach A, Soisangwan N, Billings CL, Burrack LS, Filler SG, Selmecki A. Zhou X, et al. Nat Microbiol. 2024 Sep 3. doi: 10.1038/s41564-024-01795-7. Online ahead of print. Nat Microbiol. 2024. PMID: 39227665 - Tetraploidy accelerates adaptation under drug selection in a fungal pathogen.
Avramovska O, Smith AC, Rego E, Hickman MA. Avramovska O, et al. Front Fungal Biol. 2022 Nov 16;3:984377. doi: 10.3389/ffunb.2022.984377. eCollection 2022. Front Fungal Biol. 2022. PMID: 37746235 Free PMC article. - Experimental and in-host evolution of triazole resistance in human pathogenic fungi.
Handelman M, Osherov N. Handelman M, et al. Front Fungal Biol. 2022 Aug 23;3:957577. doi: 10.3389/ffunb.2022.957577. eCollection 2022. Front Fungal Biol. 2022. PMID: 37746192 Free PMC article. Review. - Identifying Targets of Selection in Laboratory Evolution Experiments.
Martínez AA, Lang GI. Martínez AA, et al. J Mol Evol. 2023 Jun;91(3):345-355. doi: 10.1007/s00239-023-10096-2. Epub 2023 Feb 21. J Mol Evol. 2023. PMID: 36810618 Free PMC article. Review. - Loss of Heterozygosity and Its Importance in Evolution.
Smukowski Heil C. Smukowski Heil C. J Mol Evol. 2023 Jun;91(3):369-377. doi: 10.1007/s00239-022-10088-8. Epub 2023 Feb 8. J Mol Evol. 2023. PMID: 36752826 Free PMC article. Review.
References
- Arjan J A, Visser M, Zeyl C W, Gerrish P J, Blanchard J L, Lenski R E. Diminishing returns from mutation supply rate in asexual populations. Science. 1999;283:404–406. - PubMed
- Ausubel F M. Preparation of yeast RNA. In: Ausubel F M, Brent R, Kingston R E, Moore D D, Seidman J G, Smith J A, Struhl K, editors. Current protocols in molecular biology. New York, N.Y: John Wiley & Sons, Inc.; 1995. pp. 13.12.2–13.12.3.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources